Reckitt Spies Opportunity For Global Supplements Business
Executive Summary
RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.
You may also be interested in...
Reckitt Restructure Seeks To Maximize Dietary Supplement Growth
Reckitt has identified “lots of growth spaces and lots of growth potential” for its vitamins, minerals and supplements business, which it will seek to capitalize on by moving the operation to its OTC-focused Health unit.
Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal
Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.
RB Shows Scholl The Door, While Welcoming In Biofreeze
Reckitt is refocusing its consumer health portfolio by offloading the troubled Scholl brand and acquiring fast-growing US topical analgesic Biofreeze.